DuPont and The Dow Chemical Company said they are willing to divest businesses units in order to appease European Union regulators who remain skeptical of the $130 billion merger.
In a statement issued Wednesday morning, the companies offered to sell part of DuPont’s crop protection business, along with its associated research and development, and Dow Chemical’s acid copolymers and ionomers business.
The offer, which was made in a submission to the European Union’s antitrust regulator authority, known as the European Commission, has extended the merger’s deadline review until April 4.
“Dow and DuPont continue to engage constructively with the European Commission and other regulators in all relevant jurisdictions to obtain clearance for the merger, which we are confident will be achieved,” said DuPont spokesman Dan Turner in a statement. “As part of this process, we have submitted a remedy package to the European Commission that maintains the strategic logic and value creation potential of the transaction for all stakeholders.”
Full Content: The Wall Street Journal
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas